ReviewSensors (Basel, Switzerland)2026
Recent Advances in Bacterial Separation and Enrichment from Blood for the Diagnosis of Bloodstream Infections.
Review in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, recent advances (2016-2026) in bacterial separation and enrichment from blood for diagnosis of bloodstream infection (BSIs) through pathogen identification and antimicrobial susceptibility testing (AST) are reviewed. The review centers on sample processing as an indispensable front-end of biosensor and lab-on-chip platforms, since most sensors cannot operate directly in whole blood. Efficient separation and enrichment concentrate extremely low bacterial burdens, remove blood components that interfere with detection, and deliver bacteria in a sensor-compatible format; consequently, diagnostic sensitivity, specificity, turnaround time, and robustness are strongly determined by this step. We first summarize the clinical impact of BSIs and the value of rapid AST for guiding timely, targeted therapy, emphasizing that efficient bacterial isolation from blood is a prerequisite for accurate testing. We then discuss key challenges and recent progress in bacterial separation and enrichment from blood with major approaches, including filtration, centrifugation, functionalized magnetic beads, and microfluidic technologies. These strategies serve as core building blocks that interface with downstream identification and AST methods, supporting integrated biosensors and point-of-care devices. Finally, we outline future directions of bacterial separation and enrichment approaches to improve recovery, purity, integration, standardization, and overall diagnostic performance for BSI workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.